Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37776 - 37800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	MAPK13	5603	upregulated	entinostat results in increased expression of MAPK13 mRNA	6p21.31	A21037
Entinostat	Investigational	MAPK8	5599	downregulated	entinostat results in decreased expression of MAPK8 mRNA	10q11.22	A21035
Entinostat	Investigational	MARC1	64757	upregulated	entinostat results in increased expression of MARC1 mRNA	1q41	A21037
Entinostat	Investigational	MARC2	54996	upregulated	entinostat results in increased expression of MARC2 mRNA	1q41	A21037
Entinostat	Investigational	MARCKS	4082	downregulated	entinostat results in decreased expression of MARCKS mRNA	6q21	A21035
Entinostat	Investigational	MARK1	4139	downregulated	entinostat results in decreased expression of MARK1 mRNA	1q41	A21035
Entinostat	Investigational	MARVELD3	91862	upregulated	entinostat results in increased expression of MARVELD3 mRNA	16q22.2	A21037
Entinostat	Investigational	MATK	4145	upregulated	entinostat results in increased expression of MATK mRNA	19p13.3	A21035
Entinostat	Investigational	MATN2	4147	upregulated	entinostat results in increased expression of MATN2 mRNA	8q22.1-q22.2	A21037
Entinostat	Investigational	MATN3	4148	upregulated	entinostat results in increased expression of MATN3 mRNA	2p24.1	A21037 A21035
Entinostat	Investigational	MATR3	9782	upregulated	entinostat results in increased expression of MATR3 mRNA	5q31.2	A21037
Entinostat	Investigational	MB	4151	upregulated	entinostat results in increased expression of MB mRNA	22q12.3	A21037
Entinostat	Investigational	MB21D1	115004	upregulated	entinostat results in increased expression of MB21D1 mRNA	6q13	A21037
Entinostat	Investigational	MB21D2	151963	downregulated	entinostat results in decreased expression of MB21D2 mRNA	3q29	A21035
Entinostat	Investigational	MBD2	8932	upregulated	entinostat results in increased expression of MBD2 mRNA	18q21.2	A21035
Entinostat	Investigational	MBD5	55777	downregulated	entinostat results in decreased expression of MBD5 mRNA	2q23.2	A21037
Entinostat	Investigational	MBNL2	10150	downregulated	entinostat results in decreased expression of MBNL2 mRNA	13q32.1	A21037
Entinostat	Investigational	MBNL3	55796	upregulated	entinostat results in increased expression of MBNL3 mRNA	Xq26.2	A21037 A21035
Entinostat	Investigational	MBOAT1	154141	upregulated	entinostat results in increased expression of MBOAT1 mRNA	6p22.3	A21037
Entinostat	Investigational	MCAM	4162	upregulated	entinostat results in increased expression of MCAM mRNA	11q23.3	A21035
Entinostat	Investigational	MCC	4163	upregulated	entinostat results in increased expression of MCC mRNA	5q22.2	A21037
Entinostat	Investigational	MCF2L	23263	downregulated	entinostat results in decreased expression of MCF2L mRNA	13q34	A21035
Entinostat	Investigational	MCOLN3	55283	upregulated	entinostat results in increased expression of MCOLN3 mRNA	1p22.3	A21037
Entinostat	Investigational	MCRIP2	84331	upregulated	entinostat results in increased expression of MCRIP2 mRNA	16p13.3	A21037
Entinostat	Investigational	MCUB	55013	downregulated	entinostat results in decreased expression of MCUB mRNA	4q25	A21037

Displaying entries 37776 - 37800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability